单位:[1]Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430030, China华中科技大学同济医学院附属同济医院肿瘤生物医学中心[2]Wuhan Univ, Zhongnan Hosp, Hubei Key Lab Tumor Biol Behav, Dept Gynecol Oncol,Hubei Canc Clin Study Ctr, Wuhan 430071, Peoples R China[3]Peoples Hosp Shenzhen, Dept Gynecol & Obstet, Shenzhen 518000, Peoples R China
MicroRNAs (miRNAs) play critical roles in the development and progression in various cancers. Dysfunctional miR-9 expression remains ambiguous, and no consensus on the metastatic progression of ovarian cancer has been reached. In this study, results from the bioinformatics analysis show that the 3'-UTR of the E-cadherin mRNA was directly regulated by miR-9. Luciferase reporter assay results confirmed that miR-9 could directly target this 3'-UTR. miR-9 and E-cadherin expression in ovarian cancer tissue was quantified by qRT-PCR. Migration and invasion were detected by wound healing and Transwell system assay in SKOV3 and A2780. qRT-PCR and Western blot were performed to detect the epithelial. mesenchymal transition-associated mRNA and proteins. Immunofluorescence technique was used to analyze the expression and subcellular localization of Ecadherin, N-cadherin, and vimentin. The results showed that miR-9 was frequently upregulated in metastatic serous ovarian cancer tissue compared with paired primary ones. Upregulation of miR-9 could downregulate the expression of E-cadherin but upregulate the expression of mesenchymal markers (N-cadherin and vimentin). Overexpression of miR-9 could promote the cell migration and invasion in ovarian cancer, and these processes could be effectively inhibited via miR-9 inhibitor. Thus, our study demonstrates that miR-9 may promote ovarian cancer metastasis via targeting E-cadherin and a novel potential therapeutic approach to control metastasis of ovarian cancer.
基金:
This work was supported by the National Basic Research Program
of China (973 Program, No. 2015CB553903), National Natural
Science Foundation of China (Nos. 81272859, 81372801, 81230038,
81272422, 81302266, 81402163, 81402164, 81501530, and
81572569), and the Science and Technology Project of Shenzhen
(No. Jcyj20140416122811911).
第一作者单位:[1]Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430030, China[2]Wuhan Univ, Zhongnan Hosp, Hubei Key Lab Tumor Biol Behav, Dept Gynecol Oncol,Hubei Canc Clin Study Ctr, Wuhan 430071, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
zhou bo,xu hongbin,xia meng,et al.Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer[J].FRONTIERS OF MEDICINE.2017,11(2):214-222.doi:10.1007/s11684-017-0518-7.
APA:
zhou,bo,xu,hongbin,xia,meng,sun,chaoyang,li,na...&li,kezhen.(2017).Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.FRONTIERS OF MEDICINE,11,(2)
MLA:
zhou,bo,et al."Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer".FRONTIERS OF MEDICINE 11..2(2017):214-222